Emerald Health Therapeutics Inc. Receivables Turnover Ratio (EMHTF), from the fourth quarter 2019 to the fourth quarter 2018 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Emerald Health Therapeutics Inc.  (EMHTF)
 

Emerald Health Therapeutics Accounts Receivables Turnover Ratio from the fourth quarter 2019 to the fourth quarter 2018

Quarterly Results, Trends, Rankings, Statistics


Emerald Health Therapeutics Inc.'s ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2019 to a ratio of 125.3, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the fourth quarter 2019. Average receivable collection period, for the Emerald Health Therapeutics in Dec 31 2019 quarter, has decreased to 3 days, compared to 4 days, in the 0 quarter.

If we take a look into Healthcare sector 106 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Emerald Health Therapeutics Inc. Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

EMHTF Receivables Turnover Ratio (Dec 31 2019)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2018)
IV. Quarter
Y / Y Receivable Change -8.55 % - - - -
Y / Y Revenue Change 328.38 % 2895.9 % 1620.44 % 565.31 % -
Receivable Turnover Ratio (TTM) 125.3 95.17 46.74 22.44 11.09
EMHTF's Total Ranking # # # # #
Accounts Receivable average collection period days 3 4 8 16 33
Seq. Receivable Change - - - - -
Seq. Revenue Change -49.44 % 94.19 % 93.12 % 125.94 % 253.59 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 58
Healthcare Sector # 107
Overall Market #

Receivable Turnover Ratio Statistics
High Average Low
11.34 11.34 11.34
(Dec 31 2019)  





EMHTF Company Profile • Back to EMHTF Efficiency Comparisons • Compare EMHTF Receivables Turnover Ratio to its Competitors

Financial Statements
Emerald Health Therapeutics's Accounts Receivable $ 1 Millions Visit EMHTF's Balance sheet
Emerald Health Therapeutics's Sales TTM $ 17 Millions Visit EMHTF's Income Statement
Sources of EMHTF's Revenues Visit EMHTF's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
EMHTF's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
EMHTF's Growth Rates EMHTF's Roa EMHTF's Inventory Turnover Ratio EMHTF's Dividend Comparisons
EMHTF's Profitability Ratios EMHTF's Roi EMHTF's Asset Turnover Ratio EMHTF's Dividend Growth
EMHTF's Valuation Ratios EMHTF's Roe EMHTF's Financial Strength Ratios EMHTF's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2019, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2019 Receivable at quarter ending Dec 31 2019
Fate Therapeutics Inc   85.44 $ 10.680  Millions$ 0.125  Millions
U s Stem Cell Inc   84.84 $ 3.072  Millions$ 0.036  Millions
Lifemd Inc   71.33 $ 12.469  Millions$ 0.175  Millions
Biocorrx Inc   70.66 $ 0.240  Millions$ 0.003  Millions
Blueprint Medicines Corporation  69.52 $ 66.512  Millions$ 0.957  Millions
Zeo Scientifix Inc   61.50 $ 2.223  Millions$ 0.036  Millions
Wearable Health Solutions, Inc.  56.67 $ 1.694  Millions$ 0.030  Millions
Zealand Pharma A  54.92 $ 6.197  Millions$ 0.113  Millions
Scorpius Holdings inc   53.33 $ 3.049  Millions$ 0.057  Millions
Nanomix Corp  50.83 $ 0.016  Millions$ 0.000  Millions
U S Physical Therapy Inc  50.41 $ 481.969  Millions$ 9.562  Millions
Sonida Senior Living Inc   46.93 $ 447.100  Millions$ 9.527  Millions
Nature s Sunshine Products inc   45.57 $ 362.215  Millions$ 7.948  Millions
Telesis Bio Inc   45.04 $ 7.804  Millions$ 0.173  Millions
Health right Discoveries Inc   43.77 $ 3.468  Millions$ 0.079  Millions
Immunogen inc   42.04 $ 82.271  Millions$ 1.957  Millions
Innovation1 Biotech Inc   40.68 $ 0.079  Millions$ 0.002  Millions
Arrowhead Pharmaceuticals Inc   38.98 $ 163.592  Millions$ 4.197  Millions
Igc Pharma Inc   37.17 $ 5.585  Millions$ 0.150  Millions
Healthlynked Corp  37.02 $ 4.019  Millions$ 0.109  Millions
National Vision Holdings Inc   32.75 $ 1,724.331  Millions$ 52.647  Millions
Concert Pharmaceuticals Inc   32.64 $ 1.077  Millions$ 0.033  Millions
Erytech Pharma S a   29.75 $ 1.202  Millions$ 0.040  Millions
Cormedix Inc   29.53 $ 0.283  Millions$ 0.010  Millions
Brookdale Senior Living Inc   29.35 $ 4,040.403  Millions$ 137.658  Millions
Collplant Biotechnologies Ltd  29.34 $ 2.318  Millions$ 0.079  Millions
Diversicare Healthcare Services Inc   29.29 $ 475.020  Millions$ 16.219  Millions
Nymox Pharmaceutical Corporation  29.00 $ 0.116  Millions$ 0.004  Millions
Cardiff Lexington Corporation  28.89 $ 4.541  Millions$ 0.157  Millions
Agenus Inc  27.76 $ 150.048  Millions$ 5.406  Millions

Date modified: 2026-10-15T05:23:26+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.